| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | AGIOS PHARMACEUTICALS INC | 9,900 | 1,100,000 | 0.11% | ||
| 52 | BIOGEN INC | 2,600 | 1,050,000 | 0.11% | ||
| 53 | CELGENE CORP | 8,700 | 1,007,000 | 0.10% | ||
| 54 | DURECT CORP | 381,800 | 913,000 | 0.09% | ||
| 55 | ARRAY BIOPHARMA INC | 126,095 | 909,000 | 0.09% | ||
| 56 | AMGEN INC | 5,900 | 906,000 | 0.09% | ||
| 57 | WAFERGEN BIO-SYSTEMS INC | 205,400 | 647,000 | 0.07% | ||
| 58 | KERYX BIOPHARMACEUTICALS INCORPORATED | 59,200 | 591,000 | 0.06% | ||
| 59 | PUMA BIOTECHNOLOGY | 3,100 | 362,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-049028, filed 2015.08.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
